An ordinary RNA biologist

Joined April 2021
Patompon Wongtrakoongate retweeted
This is a beautiful way to visualize the pathophysiology. B cells at different stages of differentiation occupy different compartments, express different surface markers, and drive different pathologies. Based on this biology, it'd make sense that (for example) lupus would respond best to anti-CD19 therapies, while Sjögren’s would respond best to anti-BCMA -- though how that shakes out in trials isn't fully known.
Next-generation immune cell engagers for B cell depletion in autoimmune diseases nature.com/articles/s41573-0… rdcu.be/NecnUNkptUFa This Review discusses the principles guiding the design of immune cell engagers and emerging stratgeies to improve safety and durability of response
6
102
513
27,634
Patompon Wongtrakoongate retweeted
Variants in genes involved in the production of extracellular matrix molecules could have enabled the skeletal adaptations that distinguish humans from other great apes go.nature.com/4hoky1J
2
26
1
120
24,913
Patompon Wongtrakoongate retweeted
75% through the year, 44 new drugs have been approved. - 18 novel mechanisms. - 20 differentiated follow-ons. - 6 me-too’s.
2
23
2
151
14,579
Patompon Wongtrakoongate retweeted
Smaller public biotechs, with more specialist investors, tend to generate outsized returns. Which begs the question: which of today’s small biotechs have the most specialist investors? Using the full landscape of all 149 specialists, here’s the top 20. The full analysis and methods are here: breakingground.substack.com/…
Small biotech companies with no specialist investors do very badly, while those with heavy specialist concentration tend to do very well - even better than big companies.
6
10
2
107
16,250
Patompon Wongtrakoongate retweeted
An impressive study that emphasizes the role of systemic environment in the aging process an contradicts prior parabiosis work
9
42
3
252
44,742
Patompon Wongtrakoongate retweeted
Personalized neoantigen vaccines have already been shown to improve outcomes for refractory malignant melanoma and in pilot studies of pancreatic cancer, glioblastoma, renal cell carcinoma and triple negative breast cancer. But they require a tumor biopsy to identify the antigens. A new study shows it's possible to get this from a blood sample. aacrjournals.org/cancerdisco…
12
62
5
254
34,836
Patompon Wongtrakoongate retweeted
"We stabilized mRNA vaccines ....Moderna ...and Pfizer-BioNTech ....compositions into solid-state formulations that retained 100% bioactivity after storage at 37 °C for more than 2 months." That sounds almost too good to be true. #science #immunology nature.com/articles/s41587-0…
4
13
2
73
7,406
ひとつのmRNAは、ゲノムの一箇所から作られる。この前提が崩れたかもしれない。 ハーバード大のグループが、逆転写酵素を使わない直接RNAシーケンシングでマウスのマクロファージを調べたところ、別々の遺伝子の配列がつながった「キメラmRNA」が3万種以上見つかった。その約88%は、異なる染色体どうしの組み合わせ。 炎症が起きると、離れた染色体上の遺伝子が核の中で引き寄せられ、そこでRNAが正確な一点で連結される。この接近はゲノムの折りたたみを担うCTCFに依存していた。 なかでもGsdmdとTmem106aが融合したmRNAは、データベースに存在しない新しいタンパク質をコードしていた。細胞膜であらかじめ待機し、炎症性細胞死の実行役GSDMDが穴を開けるのを加速させる「先回り役」らしい。量は本家Gsdmdの1割未満だが、1割足すだけでIL-1β放出はほぼ倍に。 マウスでは、これを失うと敗血症に強くなる一方、サルモネラ感染には弱くなった。感染防御と免疫の暴走が、同じつまみの両端にぶら下がっている。 がん細胞の異常として語られてきた融合遺伝子が、健康な細胞の正常な仕組みとしても存在する。狙える創薬標的の地図には、まだ空白がありそう。 nature.com/articles/s41586-0…
1
120
17
472
36,985
Patompon Wongtrakoongate retweeted
Lipid nanoparticles optimized for large RNA cargo and tissue targeting enhance in vivo genome editing nature.com/articles/s41587-0…
3
48
2
228
22,078
Patompon Wongtrakoongate retweeted
Hearts from young donors age rapidly in the bodies of older recipients, and older hearts are rejuvenated inside young people go.nature.com/4rzzsHf
49
682
131
2,130
317,085
Patompon Wongtrakoongate retweeted
Here come the nanoparticles to help treat cancer or get rid of senescent cells, reduce fibrosis @ScienceMagazine @ScienceVisuals science.org/doi/10.1126/scie… science.org/doi/10.1126/scie…
23
91
7
356
32,513
Patompon Wongtrakoongate retweeted
In vitro induction of human germinal center B cells science.org/doi/10.1126/scii… @SciImmunology 🇯🇵
12
60
4,928
Patompon Wongtrakoongate retweeted
She lived to 117 — the oldest verified age ever recorded — and her body told two completely different stories at once. Maria Branyas had the telltale signs of extreme aging: razor-thin telomeres and an inflamed immune system. But she also carried something rare: low inflammation, a gut brimming with beneficial bacteria, and cells that were biologically younger than her 117 years. Because she never developed a major disease, researchers led by Dr. Manel Esteller at the @CarrerasIJC (Josep Carreras Leukaemia Research Institute) could finally study aging on its own, without illness clouding the picture — the most detailed biological deep-dive ever done on a supercentenarian. Their conclusion, published in Cell Reports Medicine: extreme longevity might not mean dodging aging altogether, but surviving it while holding onto the right protective traits. Curious what those traits were? Read the full study here: sciencedaily.com/releases/20… #Longevity #AgingResearch #Geroscience #Epigenetics
4
16
78
10,370
Patompon Wongtrakoongate retweeted
腫瘍免疫にT細胞受容体の特異性ってそこまで重要じゃないの?👀読まなきゃ... 9/8のNature Immunology Intratumoral T cell activation kills tumors regardless of T cell specificity nature.com/articles/s41590-0…
2
17
1
176
11,164